There is one clinical trial.

Clinical Trials

1 Exploring Brain Damages After COVID-19 Infection

Although direct evidence is currently lacking, the high identity between SARS-CoV-1 and SARS-CoV-2 suggests, that the latter viral strain could also infect the Central Nervous System (CNS). Indeed, some cases of SARS-COV2 encephalitis begin to be described and CNS damages are increasingly highlighted in the literature, but still not objectified by imaging and do not allow to explain the entire clinical patterns. We hypothesise that these CNS damages are not always objectified by Magnetic Resonance Imaging (MRI) but could be indirectly observed by a physiological dysfunction of neural conduction in the brainstem. We will explore brainstem disruption through an electrophysiological approach.

NCT04405986 SARS-CoV 2 Procedure: Auditory Evoked Potentials (AEP) Procedure: Blink and Masseter Inhibitory Reflex

MeSH:Brain Injuries

No related HPO nodes (Using clinical trials)